An Unexpected Culprit: Allergic Contact Dermatitis Caused by Benzyl Alcohol in Moist Toilet Paper. [PDF]
Contact DermatitisContact Dermatitis, Volume 95, Issue 1, Page 113-115, July 2026.
Rozas LM +3 more
europepmc +2 more sources
Palmate Erythema With Pruritus Following Contact With Lime Juice, a Variant of "Margarita Photodermatitis". [PDF]
Contact DermatitisContact Dermatitis, Volume 92, Issue 4, Page 313-315, April 2025.
Wagner JN, Zirkenbach F, Augustin M.
europepmc +2 more sources
Adult Vulval Psoriasis: Clinical Presentation, Management and Impact on Quality of Life. [PDF]
Australas J DermatolABSTRACT Background/Objectives To explore the clinical presentation, management and impact on quality of life in women with vulval psoriasis. Methods A retrospective, single‐centre cohort study of women was conducted at a large dermatology practice from January 2016 to January 2024.
Wu M, Fischer G.
europepmc +2 more sources
Zosteriform Primary Cutaneous Marginal Zone Lymphoma-A Case Report. [PDF]
Australas J DermatolABSTRACT We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
Teh N +4 more
europepmc +2 more sources
Vulval Lichen Sclerosus Associated With Immune Checkpoint Inhibitor Therapy: A Case Series of 11 Patients. [PDF]
Australas J DermatolABSTRACT There have only been a limited number of case reports that have described vulval lichen sclerosus in patients receiving immune checkpoint inhibitor (ICI) therapy. We describe 11 cases of vulval lichen sclerosus in patients with melanoma treated with ICIs, and in nine of these cases, the lichen sclerosus symptoms began after ICI commencement ...
Walter S +9 more
europepmc +2 more sources
Development and Validation of HPLC method for determination of Methylprednisolone aceponate in cream [PDF]
Macedonian Pharmaceutical Bulletin, 2022 Methylprednisolone aceponate (MPA) is an active pharmaceutical ingredient (API), used as a potent topical glucocorticoid that treats various types of eczema and psoriasis. Compared to other glucocorticoids, MPA has high efficiency and reduced application (once a day). The need to develop and validate a method for routine content determination of MPA in
Apostolova, Paulina +5 more
openaire +2 more sources
Methylprednisolone aceponate* in eczema and other inflammatory skin disorders - a clinical update
International Journal of Clinical Practice, 2006 Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous disorders, with an efficacy comparable to that of most reference topical corticosteroids. It also has excellent local and systemic tolerability.
exaly +2 more sources
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. [PDF]
J Eur Acad Dermatol VenereolDelphi Consensus on EGFRi‐induced acneiform rash: management guidelines on early diagnosis and grading, prophylactic and pre‐emptive treatment, reactive and personalized patient care. Abstract Background There is a need for unified guidance in the management of acneiform rash induced by epidermal growth factor receptor inhibitors (EGFRi) among ...
Apalla Z +34 more
europepmc +2 more sources
Topical therapy of dermatoses in children with complex localizations
Медицинский совет, 2021 The skin of children has its own anatomical and physiological characteristics, the epidermis is much thinner than in adults, the layers of the dermis and basement membrane are poorly developed and differentiated, the rate of transepidermal water loss is ...
J. S. Kovaleva +3 more
doaj +1 more source
Local Glucocorticoids in Treatment of Children with Dermatitis
Вопросы современной педиатрии, 2020 Local glucocorticoids (GCs) are the gold standard of anti-inflammatory topical therapy. The description of the main pharmaceutics properties and classification of local GCs, as well as its indications and contradictions are presented in the article. This
Yliya G. Levina +6 more
doaj +1 more source